Insights Scientific publications

Scientific publications

  • 03/03/2019

    RECIST 1.1 evaluations in a phase II clinical trial: Does reader expertise represent a risk factor for measure reliability?

    Oral presentation at the European Congress of Radiology (ECR) on Feb 27-March 3, 2019, Vienna, Austria
    Beaumont H [1], Evans T [2], Klifa C [1], Hons S [3], Chadjaa M [4], Monostori Z [5], Iannessi A [6] – Affiliations: [1] Median Technologies, Valbonne , France. [2] U. of Pennsylvania, USA. [3] Yonsei University of Medicine, Seoul, South Korea. [4] SANOFI, Vitry sur seine, France. [5] National Koranyi Institute, Budapest, Hungary. [6] Centre Antoine Lacassagne , Nice, France.
    Download ECR2019_presentation.pdf
  • 12/14/2018

    Discrepancies of assessments in a RECIST 1.1 phase II clinical trial – association between adjudication rate and variability in images and tumors selection

    In imaging-based clinical trials, it is common practice to perform double reads for each image, discrepant interpretations can result from these two different evaluations. In this study we analyzed discrepancies that occurred between local investigators (LI) and blinded independent central review (BICR) by comparing reader-selected imaging scans and lesions. Our goal was to identify the causes of discrepant declarations of progressive disease (PD) between LI and BICR in a clinical trial.
    Beaumont H [1], Evans T [2], Klifa C [1], Guermazi A [3], Hong S [4], Chadjaa M [5], Monostori Z [6] – Affiliations: [1] Median Technologies, Valbonne, France. [2] Department of medicine, Hospital of the University of Pennsylvania, USA. [3] Quantitative Imaging Center (QIC) Boston University School of Medicine, Boston, USA. [4] Department of Radiology, Severance Hospital Yonsei University of Medicine, Seoul, South Korea. [5] Clinical Research, SANOFI, Paris, France. [6] Radiology, National Koranyi Institute of TB and pulmonology, Budapest, Hungary
    Read more
  • 11/30/2018

    High Quality Imaging in Clinical Trials – Standardization mechanisms

    Presentation #18018479 at the Quantitative Imaging Reading Room, Annual Meeting of the Radiology Society of North America (RSNA) 2018; 2018 Nov. 25-29; Chicago, IL, USA
    Beaumont H – Affiliations: [1] Median Technologies, Valbonne, France
    Download Poster_RSNA_nov2018.pdf
  • 11/25/2018

    Can we improve cost effectiveness of oncology clinical trials workflow? A prospective RECIST 1.1 study

    Poster presented at ESMO ASIA 2018, Singapore, Nov. 23 -25, 2018
    Hubert Beaumont [1], Antoine Iannessi [2], Catherine Klifa [1], Sebastien Patriti [2] – Affiliations: [1] Median Technologies, Valbonne, France. [2] Centre Antoine Lacassagne, Nice, France.
    Download Poster_ESMO-Asia_nov2018.pdf
  • 11/12/2018

    Feasibility of Using Deep Learning Techniques to Assess Hepatic Fibrosis Directly from Magnetic Resonance Elastography Source Images

    Scientific poster presented at The Liver Meeting® 2018 | AASLD – San Francisco (Nov. 9 – Nov. 13, 2018). Study was performed in collaboration with Gilead and the University of California San Diego (UCSD)
    Marc-Michel Rohé [1], Estanislao Oubel [1], Marie-Lise Grisoni [1], Stephen Djedjos [2], Robert P. Myers [2], Hohit Loomba [3] and Michael S. Middleton [3] – Affiliations: [1] Median Technologies, Valbonne, France. [2] Gilead – [3] UCSD, San Diego, CA, USA
    Download 20181110_AASLD2018_Poster.pdf